Approval · Notice of Compliance 847 · 2001
ADENOCARD: Notice of Compliance 847
Issued August 28, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 847
- Date
- August 28, 2001
- Company
- Fujisawa Canada Inc.Markham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Use of parametric release instead of sterility testing for finished product testing
- Therapeutic class
- Antiarrhythmic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADENOCARD | Not yet assigned | — |
Medicinal ingredients
- ADENOSINE 3 MG per ML